The name of this superfamily has been modified since the most recent official CATH+ release (v4_2_0). At the point of the last release, this superfamily was named:

"
SRCR-like domain
".

Functional Families

Overview of the Structural Clusters (SC) and Functional Families within this CATH Superfamily. Clusters with a representative structure are represented by a filled circle.
« Back to all FunFams

FunFam 5998: Scavenger receptor cysteine-rich protein

Please note: GO annotations are assigned to the full protein sequence rather than individual protein domains. Since a given protein can contain multiple domains, it is possible that some of the annotations below come from additional domains that occur in the same protein, but have been classified elsewhere in CATH.

There are 43 GO terms relating to "molecular function"

The search results have been sorted with the annotations that are found most frequently at the top of the list. The results can be filtered by typing text into the search box at the top of the table.
GO Term Annotations Evidence
Protein binding GO:0005515
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
45 A1L4H1 (/IPI) A1L4H1 (/IPI) A1L4H1 (/IPI) A1L4H1 (/IPI) P30203 (/IPI) P58215 (/IPI) P58215 (/IPI) Q07797 (/IPI) Q60997 (/IPI) Q60997 (/IPI)
(35 more)
Zymogen binding GO:0035375
Interacting selectively and non-covalently with a zymogen, an enzymatically inactive precursor of an enzyme that is often convertible to an active enzyme by proteolysis.
30 Q4A3R3 (/ISS) Q4A3R3 (/ISS) Q4A3R3 (/ISS) Q4A3R3 (/ISS) Q8CIZ5 (/ISS) Q8CIZ5 (/ISS) Q8CIZ5 (/ISS) Q8CIZ5 (/ISS) Q95218 (/ISS) Q95218 (/ISS)
(20 more)
Scavenger receptor activity GO:0005044
Combining with any modified low-density lipoprotein (LDL) or other polyanionic ligand and delivering the ligand into the cell via endocytosis. Ligands include acetylated and oxidized LDL, Gram-positive and Gram-negative bacteria, apoptotic cells, beta-amyloid fibrils, and advanced glycation end products (AGEs).
23 Q07797 (/TAS) Q08380 (/TAS) Q86VB7 (/TAS) Q86VB7 (/TAS) Q86VB7 (/TAS) Q86VB7 (/TAS) Q86VB7 (/TAS) Q86VB7 (/TAS) Q86VB7 (/TAS) Q9UGM3 (/TAS)
(13 more)
Scavenger receptor activity GO:0005044
Combining with any modified low-density lipoprotein (LDL) or other polyanionic ligand and delivering the ligand into the cell via endocytosis. Ligands include acetylated and oxidized LDL, Gram-positive and Gram-negative bacteria, apoptotic cells, beta-amyloid fibrils, and advanced glycation end products (AGEs).
21 Q86VB7 (/NAS) Q86VB7 (/NAS) Q86VB7 (/NAS) Q86VB7 (/NAS) Q86VB7 (/NAS) Q86VB7 (/NAS) Q86VB7 (/NAS) Q9UGM3 (/NAS) Q9UGM3 (/NAS) Q9UGM3 (/NAS)
(11 more)
Protein-lysine 6-oxidase activity GO:0004720
Catalysis of the reaction: peptidyl-L-lysyl-peptide + H2O + O2 = peptidyl-allysyl-peptide + NH3 + hydrogen peroxide.
16 A6H737 (/ISS) A6H737 (/ISS) B4F6N6 (/ISS) B4F6N6 (/ISS) B5DF27 (/ISS) B5DF27 (/ISS) B8A4W9 (/ISS) B8A4W9 (/ISS) F1RD85 (/ISS) F1RD85 (/ISS)
(6 more)
Signaling pattern recognition receptor activity GO:0008329
Combining with a pathogen-associated molecular pattern (PAMP), a structure conserved among microbial species, or damage-associated molecular pattern (DAMP), an endogenous molecule released from damaged cells), and transmitting a signal to initiate a change in cell activity.
14 Q9UGM3 (/TAS) Q9UGM3 (/TAS) Q9UGM3 (/TAS) Q9UGM3 (/TAS) Q9UGM3 (/TAS) Q9UGM3 (/TAS) Q9UGM3 (/TAS) Q9UGM3 (/TAS) Q9UGM3 (/TAS) Q9UGM3 (/TAS)
(4 more)
Calcium-dependent protein binding GO:0048306
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules), in the presence of calcium.
14 Q9UGM3 (/TAS) Q9UGM3 (/TAS) Q9UGM3 (/TAS) Q9UGM3 (/TAS) Q9UGM3 (/TAS) Q9UGM3 (/TAS) Q9UGM3 (/TAS) Q9UGM3 (/TAS) Q9UGM3 (/TAS) Q9UGM3 (/TAS)
(4 more)
Oligosaccharide binding GO:0070492
Interacting selectively and non-covalently with any oligosaccharide, a molecule with between two and (about) 20 monosaccharide residues connected by glycosidic linkages.
12 A6H737 (/ISS) A6H737 (/ISS) B4F6N6 (/ISS) B4F6N6 (/ISS) B5DF27 (/ISS) B5DF27 (/ISS) P58022 (/ISS) P58022 (/ISS) Q08B63 (/ISS) Q08B63 (/ISS)
(2 more)
Fibronectin binding GO:0001968
Interacting selectively and non-covalently with a fibronectin, a group of related adhesive glycoproteins of high molecular weight found on the surface of animal cells, connective tissue matrices, and in extracellular fluids.
10 A1L4H1 (/ISS) A1L4H1 (/ISS) A1L4H1 (/ISS) A1L4H1 (/ISS) B8A4W9 (/ISS) B8A4W9 (/ISS) F1RD85 (/ISS) F1RD85 (/ISS) P58215 (/ISS) P58215 (/ISS)
Chromatin binding GO:0003682
Interacting selectively and non-covalently with chromatin, the network of fibers of DNA, protein, and sometimes RNA, that make up the chromosomes of the eukaryotic nucleus during interphase.
8 A6H737 (/ISS) A6H737 (/ISS) B5DF27 (/ISS) B5DF27 (/ISS) P58022 (/ISS) P58022 (/ISS) Q5RFQ6 (/ISS) Q5RFQ6 (/ISS)
Transcription corepressor activity GO:0003714
Interacting selectively and non-covalently with a repressing transcription factor and also with the basal transcription machinery in order to stop, prevent, or reduce the frequency, rate or extent of transcription. Cofactors generally do not bind the template nucleic acid, but rather mediate protein-protein interactions between repressive transcription factors and the basal transcription machinery.
8 A6H737 (/ISS) A6H737 (/ISS) B5DF27 (/ISS) B5DF27 (/ISS) P58022 (/ISS) P58022 (/ISS) Q5RFQ6 (/ISS) Q5RFQ6 (/ISS)
Methylated histone binding GO:0035064
Interacting selectively and non-covalently with a histone protein in which a residue has been modified by methylation. Histones are any of a group of water-soluble proteins found in association with the DNA of plant and animal chromosomes.
8 A6H737 (/ISS) A6H737 (/ISS) B5DF27 (/ISS) B5DF27 (/ISS) P58022 (/ISS) P58022 (/ISS) Q5RFQ6 (/ISS) Q5RFQ6 (/ISS)
Zymogen binding GO:0035375
Interacting selectively and non-covalently with a zymogen, an enzymatically inactive precursor of an enzyme that is often convertible to an active enzyme by proteolysis.
8 Q60997 (/IDA) Q60997 (/IDA) Q60997 (/IDA) Q60997 (/IDA) Q60997 (/IDA) Q60997 (/IDA) Q60997 (/IDA) Q60997 (/IDA)
Fibronectin binding GO:0001968
Interacting selectively and non-covalently with a fibronectin, a group of related adhesive glycoproteins of high molecular weight found on the surface of animal cells, connective tissue matrices, and in extracellular fluids.
7 Q8BV57 (/IDA) Q8BV57 (/IDA) Q8BV57 (/IDA) Q8BV57 (/IDA) Q8BV57 (/IDA) Q9Z175 (/IDA) Q9Z175 (/IDA)
Scavenger receptor activity GO:0005044
Combining with any modified low-density lipoprotein (LDL) or other polyanionic ligand and delivering the ligand into the cell via endocytosis. Ligands include acetylated and oxidized LDL, Gram-positive and Gram-negative bacteria, apoptotic cells, beta-amyloid fibrils, and advanced glycation end products (AGEs).
7 Q2VLH6 (/ISO) Q2VLH6 (/ISO) Q2VLH6 (/ISO) Q2VLH6 (/ISO) Q2VLH6 (/ISO) Q2VLH6 (/ISO) Q2VLH6 (/ISO)
Protein-lysine 6-oxidase activity GO:0004720
Catalysis of the reaction: peptidyl-L-lysyl-peptide + H2O + O2 = peptidyl-allysyl-peptide + NH3 + hydrogen peroxide.
6 P58215 (/IDA) P58215 (/IDA) Q9Y4K0 (/IDA) Q9Y4K0 (/IDA) Q9Z175 (/IDA) Q9Z175 (/IDA)
Scavenger receptor activity GO:0005044
Combining with any modified low-density lipoprotein (LDL) or other polyanionic ligand and delivering the ligand into the cell via endocytosis. Ligands include acetylated and oxidized LDL, Gram-positive and Gram-negative bacteria, apoptotic cells, beta-amyloid fibrils, and advanced glycation end products (AGEs).
5 Q8BV57 (/IDA) Q8BV57 (/IDA) Q8BV57 (/IDA) Q8BV57 (/IDA) Q8BV57 (/IDA)
Scavenger receptor activity GO:0005044
Combining with any modified low-density lipoprotein (LDL) or other polyanionic ligand and delivering the ligand into the cell via endocytosis. Ligands include acetylated and oxidized LDL, Gram-positive and Gram-negative bacteria, apoptotic cells, beta-amyloid fibrils, and advanced glycation end products (AGEs).
5 A1L4H1 (/ISS) A1L4H1 (/ISS) A1L4H1 (/ISS) A1L4H1 (/ISS) Q07797 (/ISS)
Laminin binding GO:0043236
Interacting selectively and non-covalently with laminins, glycoproteins that are major constituents of the basement membrane of cells.
5 Q8BV57 (/IDA) Q8BV57 (/IDA) Q8BV57 (/IDA) Q8BV57 (/IDA) Q8BV57 (/IDA)
Extracellular matrix binding GO:0050840
Interacting selectively and non-covalently with a component of the extracellular matrix.
5 Q8BV57 (/IDA) Q8BV57 (/IDA) Q8BV57 (/IDA) Q8BV57 (/IDA) Q8BV57 (/IDA)
Protein-lysine 6-oxidase activity GO:0004720
Catalysis of the reaction: peptidyl-L-lysyl-peptide + H2O + O2 = peptidyl-allysyl-peptide + NH3 + hydrogen peroxide.
4 P58022 (/ISO) P58022 (/ISO) Q9Z175 (/ISO) Q9Z175 (/ISO)
Laminin binding GO:0043236
Interacting selectively and non-covalently with laminins, glycoproteins that are major constituents of the basement membrane of cells.
4 A1L4H1 (/ISS) A1L4H1 (/ISS) A1L4H1 (/ISS) A1L4H1 (/ISS)
Extracellular matrix binding GO:0050840
Interacting selectively and non-covalently with a component of the extracellular matrix.
4 A1L4H1 (/ISS) A1L4H1 (/ISS) A1L4H1 (/ISS) A1L4H1 (/ISS)
Ferritin receptor activity GO:0070287
Combining with ferritin, and delivering ferritin into the cell via endocytosis.
3 A5PJQ2 (/ISS) Q5RFW0 (/ISS) Q6ZMJ2 (/ISS)
Glycoprotein binding GO:0001948
Interacting selectively and non-covalently with a glycoprotein, a protein that contains covalently bound glycose (monosaccharide) residues. These also include proteoglycans.
2 G3V8U0 (/IPI) Q5FVU4 (/IPI)
Chromatin binding GO:0003682
Interacting selectively and non-covalently with chromatin, the network of fibers of DNA, protein, and sometimes RNA, that make up the chromosomes of the eukaryotic nucleus during interphase.
2 Q9Y4K0 (/IDA) Q9Y4K0 (/IDA)
Chromatin binding GO:0003682
Interacting selectively and non-covalently with chromatin, the network of fibers of DNA, protein, and sometimes RNA, that make up the chromosomes of the eukaryotic nucleus during interphase.
2 P58022 (/ISO) P58022 (/ISO)
Transcription corepressor activity GO:0003714
Interacting selectively and non-covalently with a repressing transcription factor and also with the basal transcription machinery in order to stop, prevent, or reduce the frequency, rate or extent of transcription. Cofactors generally do not bind the template nucleic acid, but rather mediate protein-protein interactions between repressive transcription factors and the basal transcription machinery.
2 Q9Y4K0 (/IDA) Q9Y4K0 (/IDA)
Transcription corepressor activity GO:0003714
Interacting selectively and non-covalently with a repressing transcription factor and also with the basal transcription machinery in order to stop, prevent, or reduce the frequency, rate or extent of transcription. Cofactors generally do not bind the template nucleic acid, but rather mediate protein-protein interactions between repressive transcription factors and the basal transcription machinery.
2 P58022 (/ISO) P58022 (/ISO)
Protein-lysine 6-oxidase activity GO:0004720
Catalysis of the reaction: peptidyl-L-lysyl-peptide + H2O + O2 = peptidyl-allysyl-peptide + NH3 + hydrogen peroxide.
2 P58215 (/NAS) P58215 (/NAS)
Copper ion binding GO:0005507
Interacting selectively and non-covalently with copper (Cu) ions.
2 P58215 (/NAS) P58215 (/NAS)
Electron carrier activity GO:0009055
Any molecular entity that serves as an electron acceptor and electron donor in an electron transport chain. An electron transport chain is a process in which a series of electron carriers operate together to transfer electrons from donors to any of several different terminal electron acceptors to generate a transmembrane electrochemical gradient.
2 Q9Y4K0 (/TAS) Q9Y4K0 (/TAS)
Protein kinase binding GO:0019901
Interacting selectively and non-covalently with a protein kinase, any enzyme that catalyzes the transfer of a phosphate group, usually from ATP, to a protein substrate.
2 G3V8U0 (/IDA) Q5FVU4 (/IDA)
Methylated histone binding GO:0035064
Interacting selectively and non-covalently with a histone protein in which a residue has been modified by methylation. Histones are any of a group of water-soluble proteins found in association with the DNA of plant and animal chromosomes.
2 Q9Y4K0 (/IDA) Q9Y4K0 (/IDA)
Methylated histone binding GO:0035064
Interacting selectively and non-covalently with a histone protein in which a residue has been modified by methylation. Histones are any of a group of water-soluble proteins found in association with the DNA of plant and animal chromosomes.
2 P58022 (/ISO) P58022 (/ISO)
Oligosaccharide binding GO:0070492
Interacting selectively and non-covalently with any oligosaccharide, a molecule with between two and (about) 20 monosaccharide residues connected by glycosidic linkages.
2 Q9Y4K0 (/IDA) Q9Y4K0 (/IDA)
Oligosaccharide binding GO:0070492
Interacting selectively and non-covalently with any oligosaccharide, a molecule with between two and (about) 20 monosaccharide residues connected by glycosidic linkages.
2 P58022 (/ISO) P58022 (/ISO)
Lipopolysaccharide binding GO:0001530
Interacting selectively and non-covalently with lipopolysaccharide.
1 P30203 (/IDA)
Lipopolysaccharide binding GO:0001530
Interacting selectively and non-covalently with lipopolysaccharide.
1 Q61003 (/ISO)
Lipopolysaccharide binding GO:0001530
Interacting selectively and non-covalently with lipopolysaccharide.
1 Q61003 (/ISS)
Lipoteichoic acid binding GO:0070891
Interacting selectively and non-covalently with lipoteichoic acid.
1 P30203 (/IMP)
Lipoteichoic acid binding GO:0070891
Interacting selectively and non-covalently with lipoteichoic acid.
1 Q61003 (/ISO)
Lipoteichoic acid binding GO:0070891
Interacting selectively and non-covalently with lipoteichoic acid.
1 Q61003 (/ISS)

There are 118 GO terms relating to "biological process"

The search results have been sorted with the annotations that are found most frequently at the top of the list. The results can be filtered by typing text into the search box at the top of the table.
GO Term Annotations Evidence
Defense response to Gram-negative bacterium GO:0050829
Reactions triggered in response to the presence of a Gram-negative bacterium that act to protect the cell or organism.
30 Q4A3R3 (/ISS) Q4A3R3 (/ISS) Q4A3R3 (/ISS) Q4A3R3 (/ISS) Q8CIZ5 (/ISS) Q8CIZ5 (/ISS) Q8CIZ5 (/ISS) Q8CIZ5 (/ISS) Q95218 (/ISS) Q95218 (/ISS)
(20 more)
Defense response to Gram-positive bacterium GO:0050830
Reactions triggered in response to the presence of a Gram-positive bacterium that act to protect the cell or organism.
30 Q4A3R3 (/ISS) Q4A3R3 (/ISS) Q4A3R3 (/ISS) Q4A3R3 (/ISS) Q8CIZ5 (/ISS) Q8CIZ5 (/ISS) Q8CIZ5 (/ISS) Q8CIZ5 (/ISS) Q95218 (/ISS) Q95218 (/ISS)
(20 more)
Epithelial to mesenchymal transition GO:0001837
A transition where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
20 A1L1V4 (/ISS) A1L1V4 (/ISS) A6H737 (/ISS) A6H737 (/ISS) B4F6N6 (/ISS) B4F6N6 (/ISS) B5DF27 (/ISS) B5DF27 (/ISS) E1C3U7 (/ISS) E1C3U7 (/ISS)
(10 more)
Negative regulation of transcription, DNA-templated GO:0045892
Any process that stops, prevents, or reduces the frequency, rate or extent of cellular DNA-templated transcription.
20 A1L1V4 (/ISS) A1L1V4 (/ISS) A6H737 (/ISS) A6H737 (/ISS) B4F6N6 (/ISS) B4F6N6 (/ISS) B5DF27 (/ISS) B5DF27 (/ISS) E1C3U7 (/ISS) E1C3U7 (/ISS)
(10 more)
Response to hypoxia GO:0001666
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.
18 A1L1V4 (/ISS) A1L1V4 (/ISS) A6H737 (/ISS) A6H737 (/ISS) B4F6N6 (/ISS) B4F6N6 (/ISS) B5DF27 (/ISS) B5DF27 (/ISS) E1C3U7 (/ISS) E1C3U7 (/ISS)
(8 more)
Endothelial cell proliferation GO:0001935
The multiplication or reproduction of endothelial cells, resulting in the expansion of a cell population. Endothelial cells are thin flattened cells which line the inside surfaces of body cavities, blood vessels, and lymph vessels, making up the endothelium.
18 A1L1V4 (/ISS) A1L1V4 (/ISS) A6H737 (/ISS) A6H737 (/ISS) B4F6N6 (/ISS) B4F6N6 (/ISS) B5DF27 (/ISS) B5DF27 (/ISS) E1C3U7 (/ISS) E1C3U7 (/ISS)
(8 more)
Collagen fibril organization GO:0030199
Any process that determines the size and arrangement of collagen fibrils within an extracellular matrix.
18 A1L1V4 (/ISS) A1L1V4 (/ISS) A6H737 (/ISS) A6H737 (/ISS) B4F6N6 (/ISS) B4F6N6 (/ISS) B5DF27 (/ISS) B5DF27 (/ISS) E1C3U7 (/ISS) E1C3U7 (/ISS)
(8 more)
Positive regulation of chondrocyte differentiation GO:0032332
Any process that activates or increases the frequency, rate or extent of chondrocyte differentiation.
18 A1L1V4 (/ISS) A1L1V4 (/ISS) A6H737 (/ISS) A6H737 (/ISS) B4F6N6 (/ISS) B4F6N6 (/ISS) B5DF27 (/ISS) B5DF27 (/ISS) E1C3U7 (/ISS) E1C3U7 (/ISS)
(8 more)
Endothelial cell migration GO:0043542
The orderly movement of an endothelial cell into the extracellular matrix to form an endothelium.
18 A1L1V4 (/ISS) A1L1V4 (/ISS) A6H737 (/ISS) A6H737 (/ISS) B4F6N6 (/ISS) B4F6N6 (/ISS) B5DF27 (/ISS) B5DF27 (/ISS) E1C3U7 (/ISS) E1C3U7 (/ISS)
(8 more)
Sprouting angiogenesis GO:0002040
The extension of new blood vessels from existing capillaries into avascular tissues resulting from the proliferation of blood vessel endothelial cells.
16 A1L1V4 (/ISS) A1L1V4 (/ISS) A6H737 (/ISS) A6H737 (/ISS) B4F6N6 (/ISS) B4F6N6 (/ISS) B5DF27 (/ISS) B5DF27 (/ISS) E1C3U7 (/ISS) E1C3U7 (/ISS)
(6 more)
Epithelial cell differentiation GO:0030855
The process in which a relatively unspecialized cell acquires specialized features of an epithelial cell, any of the cells making up an epithelium.
14 Q9UGM3 (/NAS) Q9UGM3 (/NAS) Q9UGM3 (/NAS) Q9UGM3 (/NAS) Q9UGM3 (/NAS) Q9UGM3 (/NAS) Q9UGM3 (/NAS) Q9UGM3 (/NAS) Q9UGM3 (/NAS) Q9UGM3 (/NAS)
(4 more)
Epithelial cell differentiation GO:0030855
The process in which a relatively unspecialized cell acquires specialized features of an epithelial cell, any of the cells making up an epithelium.
14 Q9UGM3 (/TAS) Q9UGM3 (/TAS) Q9UGM3 (/TAS) Q9UGM3 (/TAS) Q9UGM3 (/TAS) Q9UGM3 (/TAS) Q9UGM3 (/TAS) Q9UGM3 (/TAS) Q9UGM3 (/TAS) Q9UGM3 (/TAS)
(4 more)
Induction of bacterial agglutination GO:0043152
Any process in which infecting bacteria are clumped together by a host organism.
14 Q9UGM3 (/TAS) Q9UGM3 (/TAS) Q9UGM3 (/TAS) Q9UGM3 (/TAS) Q9UGM3 (/TAS) Q9UGM3 (/TAS) Q9UGM3 (/TAS) Q9UGM3 (/TAS) Q9UGM3 (/TAS) Q9UGM3 (/TAS)
(4 more)
Cellular protein metabolic process GO:0044267
The chemical reactions and pathways involving a specific protein, rather than of proteins in general, occurring at the level of an individual cell. Includes cellular protein modification.
14 Q9UGM3 (/TAS) Q9UGM3 (/TAS) Q9UGM3 (/TAS) Q9UGM3 (/TAS) Q9UGM3 (/TAS) Q9UGM3 (/TAS) Q9UGM3 (/TAS) Q9UGM3 (/TAS) Q9UGM3 (/TAS) Q9UGM3 (/TAS)
(4 more)
Innate immune response GO:0045087
Innate immune responses are defense responses mediated by germline encoded components that directly recognize components of potential pathogens.
14 Q9UGM3 (/TAS) Q9UGM3 (/TAS) Q9UGM3 (/TAS) Q9UGM3 (/TAS) Q9UGM3 (/TAS) Q9UGM3 (/TAS) Q9UGM3 (/TAS) Q9UGM3 (/TAS) Q9UGM3 (/TAS) Q9UGM3 (/TAS)
(4 more)
Defense response to Gram-negative bacterium GO:0050829
Reactions triggered in response to the presence of a Gram-negative bacterium that act to protect the cell or organism.
13 Q60997 (/IDA) Q60997 (/IDA) Q60997 (/IDA) Q60997 (/IDA) Q60997 (/IDA) Q60997 (/IDA) Q60997 (/IDA) Q60997 (/IDA) Q8BV57 (/IDA) Q8BV57 (/IDA)
(3 more)
Defense response to Gram-positive bacterium GO:0050830
Reactions triggered in response to the presence of a Gram-positive bacterium that act to protect the cell or organism.
13 Q60997 (/IDA) Q60997 (/IDA) Q60997 (/IDA) Q60997 (/IDA) Q60997 (/IDA) Q60997 (/IDA) Q60997 (/IDA) Q60997 (/IDA) Q8BV57 (/IDA) Q8BV57 (/IDA)
(3 more)
Cellular protein modification process GO:0006464
The covalent alteration of one or more amino acids occurring in proteins, peptides and nascent polypeptides (co-translational, post-translational modifications) occurring at the level of an individual cell. Includes the modification of charged tRNAs that are destined to occur in a protein (pre-translation modification).
12 A6H737 (/ISS) A6H737 (/ISS) B4F6N6 (/ISS) B4F6N6 (/ISS) B5DF27 (/ISS) B5DF27 (/ISS) P58022 (/ISS) P58022 (/ISS) Q08B63 (/ISS) Q08B63 (/ISS)
(2 more)
Receptor-mediated endocytosis GO:0006898
An endocytosis process in which cell surface receptors ensure specificity of transport. A specific receptor on the cell surface binds tightly to the extracellular macromolecule (the ligand) that it recognizes; the plasma-membrane region containing the receptor-ligand complex then undergoes endocytosis, forming a transport vesicle containing the receptor-ligand complex and excluding most other plasma-membrane proteins. Receptor-mediated endocytosis generally occurs via clathrin-coated pits and vesicles.
12 Q86VB7 (/TAS) Q86VB7 (/TAS) Q86VB7 (/TAS) Q86VB7 (/TAS) Q86VB7 (/TAS) Q86VB7 (/TAS) Q86VB7 (/TAS) Q8BV57 (/TAS) Q8BV57 (/TAS) Q8BV57 (/TAS)
(2 more)
Response to copper ion GO:0046688
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a copper ion stimulus.
12 A6H737 (/ISS) A6H737 (/ISS) B4F6N6 (/ISS) B4F6N6 (/ISS) B5DF27 (/ISS) B5DF27 (/ISS) P58022 (/ISS) P58022 (/ISS) Q08B63 (/ISS) Q08B63 (/ISS)
(2 more)
Gamma-delta T cell lineage commitment GO:0002365
The process in which a pro-T cell becomes committed to becoming a gamma-delta T cell.
10 B3F5L4 (/IDA) B3F5L4 (/IDA) B3F5L4 (/IDA) B3F5L4 (/IDA) B3F5L5 (/IDA) B3F5L5 (/IDA) B3F5L5 (/IDA) B3F5L5 (/IDA) Q8C9T4 (/IDA) Q8C9T4 (/IDA)
Interleukin-17 production GO:0032620
The appearance of any member of the interleukin-17 family of cytokines due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
10 B3F5L4 (/IDA) B3F5L4 (/IDA) B3F5L4 (/IDA) B3F5L4 (/IDA) B3F5L5 (/IDA) B3F5L5 (/IDA) B3F5L5 (/IDA) B3F5L5 (/IDA) Q8C9T4 (/IDA) Q8C9T4 (/IDA)
Blastocyst development GO:0001824
The process whose specific outcome is the progression of the blastocyst over time, from its formation to the mature structure. The mammalian blastocyst is a hollow ball of cells containing two cell types, the inner cell mass and the trophectoderm.
8 Q60997 (/IMP) Q60997 (/IMP) Q60997 (/IMP) Q60997 (/IMP) Q60997 (/IMP) Q60997 (/IMP) Q60997 (/IMP) Q60997 (/IMP)
Inner cell mass cell proliferation GO:0001833
The proliferation of cells in the inner cell mass.
8 Q60997 (/IDA) Q60997 (/IDA) Q60997 (/IDA) Q60997 (/IDA) Q60997 (/IDA) Q60997 (/IDA) Q60997 (/IDA) Q60997 (/IDA)
Histone modification GO:0016570
The covalent alteration of one or more amino acid residues within a histone protein.
8 A6H737 (/ISS) A6H737 (/ISS) B5DF27 (/ISS) B5DF27 (/ISS) P58022 (/ISS) P58022 (/ISS) Q5RFQ6 (/ISS) Q5RFQ6 (/ISS)
Protein deamination GO:0018277
The removal of an amino group from a protein amino acid.
8 A6H737 (/ISS) A6H737 (/ISS) B5DF27 (/ISS) B5DF27 (/ISS) P58022 (/ISS) P58022 (/ISS) Q5RFQ6 (/ISS) Q5RFQ6 (/ISS)
Positive regulation of epithelial cell differentiation GO:0030858
Any process that activates or increases the frequency, rate or extent of epithelial cell differentiation.
8 Q60997 (/IDA) Q60997 (/IDA) Q60997 (/IDA) Q60997 (/IDA) Q60997 (/IDA) Q60997 (/IDA) Q60997 (/IDA) Q60997 (/IDA)
Oxidation-reduction process GO:0055114
A metabolic process that results in the removal or addition of one or more electrons to or from a substance, with or without the concomitant removal or addition of a proton or protons.
8 A6H737 (/ISS) A6H737 (/ISS) B5DF27 (/ISS) B5DF27 (/ISS) P58022 (/ISS) P58022 (/ISS) Q5RFQ6 (/ISS) Q5RFQ6 (/ISS)
Inflammatory response GO:0006954
The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages.
6 B8A4W9 (/ISS) B8A4W9 (/ISS) F1RD85 (/ISS) F1RD85 (/ISS) P58215 (/ISS) P58215 (/ISS)
Spinal cord development GO:0021510
The process whose specific outcome is the progression of the spinal cord over time, from its formation to the mature structure. The spinal cord primarily conducts sensory and motor nerve impulses between the brain and the peripheral nervous tissues.
6 B8A4W9 (/ISS) B8A4W9 (/ISS) F1RD85 (/ISS) F1RD85 (/ISS) P58215 (/ISS) P58215 (/ISS)
Lung development GO:0030324
The process whose specific outcome is the progression of the lung over time, from its formation to the mature structure. In all air-breathing vertebrates the lungs are developed from the ventral wall of the oesophagus as a pouch which divides into two sacs. In amphibians and many reptiles the lungs retain very nearly this primitive sac-like character, but in the higher forms the connection with the esophagus becomes elongated into the windpipe and the inner walls of the sacs become more and more divided, until, in the mammals, the air spaces become minutely divided into tubes ending in small air cells, in the walls of which the blood circulates in a fine network of capillaries. In mammals the lungs are more or less divided into lobes, and each lung occupies a separate cavity in the thorax.
6 B8A4W9 (/ISS) B8A4W9 (/ISS) F1RD85 (/ISS) F1RD85 (/ISS) P58215 (/ISS) P58215 (/ISS)
Palate development GO:0060021
The biological process whose specific outcome is the progression of the palate from an initial condition to its mature state. This process begins with the formation of the structure and ends with the mature structure. The palate is the partition that separates the nasal and oral cavities.
6 B8A4W9 (/ISS) B8A4W9 (/ISS) F1RD85 (/ISS) F1RD85 (/ISS) P58215 (/ISS) P58215 (/ISS)
Somite development GO:0061053
The progression of a somite from its initial formation to the mature structure. Somites are mesodermal clusters that are arranged segmentally along the anterior posterior axis of an embryo.
6 B8A4W9 (/ISS) B8A4W9 (/ISS) F1RD85 (/ISS) F1RD85 (/ISS) P58215 (/ISS) P58215 (/ISS)
Fibronectin fibril organization GO:1905590
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a fibronectin fibril.
6 B8A4W9 (/ISS) B8A4W9 (/ISS) F1RD85 (/ISS) F1RD85 (/ISS) P58215 (/ISS) P58215 (/ISS)
Negative regulation of T-helper 17 cell lineage commitment GO:2000329
Any process that stops, prevents or reduces the frequency, rate or extent of T-helper 17 cell lineage commitment.
6 B8A4W9 (/ISS) B8A4W9 (/ISS) F1RD85 (/ISS) F1RD85 (/ISS) P58215 (/ISS) P58215 (/ISS)
Positive regulation of integrin-mediated signaling pathway GO:2001046
Any process that activates or increases the frequency, rate or extent of integrin-mediated signaling pathway.
6 B8A4W9 (/ISS) B8A4W9 (/ISS) F1RD85 (/ISS) F1RD85 (/ISS) P58215 (/ISS) P58215 (/ISS)
Defense response GO:0006952
Reactions, triggered in response to the presence of a foreign body or the occurrence of an injury, which result in restriction of damage to the organism attacked or prevention/recovery from the infection caused by the attack.
5 Q8BV57 (/IDA) Q8BV57 (/IDA) Q8BV57 (/IDA) Q8BV57 (/IDA) Q8BV57 (/IDA)
Detection of bacterial lipoprotein GO:0042494
The series of events in which a bacterial lipoprotein stimulus is received by a cell and converted into a molecular signal. Bacterial lipoproteins are lipoproteins characterized by the presence of conserved sequence motifs called pathogen-associated molecular patterns (PAMPs).
5 Q8BV57 (/IDA) Q8BV57 (/IDA) Q8BV57 (/IDA) Q8BV57 (/IDA) Q8BV57 (/IDA)
Innate immune response GO:0045087
Innate immune responses are defense responses mediated by germline encoded components that directly recognize components of potential pathogens.
5 Q8BV57 (/NAS) Q8BV57 (/NAS) Q8BV57 (/NAS) Q8BV57 (/NAS) Q8BV57 (/NAS)
Regulation of interleukin-8 secretion GO:2000482
Any process that modulates the frequency, rate or extent of interleukin-8 secretion.
5 Q8BV57 (/IDA) Q8BV57 (/IDA) Q8BV57 (/IDA) Q8BV57 (/IDA) Q8BV57 (/IDA)
Negative regulation of interleukin-8 secretion GO:2000483
Any process that stops, prevents or reduces the frequency, rate or extent of interleukin-8 secretion.
5 Q8BV57 (/IDA) Q8BV57 (/IDA) Q8BV57 (/IDA) Q8BV57 (/IDA) Q8BV57 (/IDA)
Epithelial to mesenchymal transition GO:0001837
A transition where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
4 P58215 (/IDA) P58215 (/IDA) Q9Y4K0 (/IDA) Q9Y4K0 (/IDA)
Epithelial to mesenchymal transition GO:0001837
A transition where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
4 P58022 (/ISO) P58022 (/ISO) Q9Z175 (/ISO) Q9Z175 (/ISO)
Sprouting angiogenesis GO:0002040
The extension of new blood vessels from existing capillaries into avascular tissues resulting from the proliferation of blood vessel endothelial cells.
4 F1QQC3 (/IMP) F1QQC3 (/IMP) Q9Y4K0 (/IMP) Q9Y4K0 (/IMP)
Response to wounding GO:0009611
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating damage to the organism.
4 Q8CIZ5 (/IEP) Q8CIZ5 (/IEP) Q8CIZ5 (/IEP) Q8CIZ5 (/IEP)
Response to organic substance GO:0010033
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic substance stimulus.
4 Q8CIZ5 (/IEP) Q8CIZ5 (/IEP) Q8CIZ5 (/IEP) Q8CIZ5 (/IEP)
Peptidyl-lysine oxidation GO:0018057
The oxidation of the terminal amino-methylene groups of peptidyl-L-lysine or peptidyl-5-hydroxy-L-lysine to aldehyde groups to form allysine or hydroxyallysine residues, respectively; these are intermediates in the formation of covalent cross-links between adjacent polypeptide chains in proteins such as collagens.
4 P58215 (/IDA) P58215 (/IDA) Q9Z175 (/IDA) Q9Z175 (/IDA)
Peptidyl-lysine oxidation GO:0018057
The oxidation of the terminal amino-methylene groups of peptidyl-L-lysine or peptidyl-5-hydroxy-L-lysine to aldehyde groups to form allysine or hydroxyallysine residues, respectively; these are intermediates in the formation of covalent cross-links between adjacent polypeptide chains in proteins such as collagens.
4 B8A4W9 (/ISS) B8A4W9 (/ISS) F1RD85 (/ISS) F1RD85 (/ISS)
Cell differentiation GO:0030154
The process in which relatively unspecialized cells, e.g. embryonic or regenerative cells, acquire specialized structural and/or functional features that characterize the cells, tissues, or organs of the mature organism or some other relatively stable phase of the organism's life history. Differentiation includes the processes involved in commitment of a cell to a specific fate and its subsequent development to the mature state.
4 Q8CIZ5 (/IEP) Q8CIZ5 (/IEP) Q8CIZ5 (/IEP) Q8CIZ5 (/IEP)
Tissue regeneration GO:0042246
The regrowth of lost or destroyed tissues.
4 Q8CIZ5 (/IEP) Q8CIZ5 (/IEP) Q8CIZ5 (/IEP) Q8CIZ5 (/IEP)
Detection of bacterial lipoprotein GO:0042494
The series of events in which a bacterial lipoprotein stimulus is received by a cell and converted into a molecular signal. Bacterial lipoproteins are lipoproteins characterized by the presence of conserved sequence motifs called pathogen-associated molecular patterns (PAMPs).
4 A1L4H1 (/ISS) A1L4H1 (/ISS) A1L4H1 (/ISS) A1L4H1 (/ISS)
Response to estrogen GO:0043627
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by an estrogen, C18 steroid hormones that can stimulate the development of female sexual characteristics.
4 Q8CIZ5 (/IEP) Q8CIZ5 (/IEP) Q8CIZ5 (/IEP) Q8CIZ5 (/IEP)
Negative regulation of transcription, DNA-templated GO:0045892
Any process that stops, prevents, or reduces the frequency, rate or extent of cellular DNA-templated transcription.
4 P58215 (/IDA) P58215 (/IDA) Q9Y4K0 (/IDA) Q9Y4K0 (/IDA)
Negative regulation of transcription, DNA-templated GO:0045892
Any process that stops, prevents, or reduces the frequency, rate or extent of cellular DNA-templated transcription.
4 P58022 (/ISO) P58022 (/ISO) Q9Z175 (/ISO) Q9Z175 (/ISO)
Negative regulation of interleukin-8 secretion GO:2000483
Any process that stops, prevents or reduces the frequency, rate or extent of interleukin-8 secretion.
4 A1L4H1 (/ISS) A1L4H1 (/ISS) A1L4H1 (/ISS) A1L4H1 (/ISS)
Cellular iron ion homeostasis GO:0006879
Any process involved in the maintenance of an internal steady state of iron ions at the level of a cell.
3 A5PJQ2 (/ISS) Q5RFW0 (/ISS) Q6ZMJ2 (/ISS)
Endocytosis GO:0006897
A vesicle-mediated transport process in which cells take up external materials or membrane constituents by the invagination of a small region of the plasma membrane to form a new membrane-bounded vesicle.
3 A5PJQ2 (/ISS) Q5RFW0 (/ISS) Q6ZMJ2 (/ISS)
Cellular defense response GO:0006968
A defense response that is mediated by cells.
3 O43866 (/TAS) O43866 (/TAS) Q08380 (/TAS)
Iron ion transmembrane transport GO:0034755
A process in which an iron ion is transported from one side of a membrane to the other by means of some agent such as a transporter or pore.
3 A5PJQ2 (/ISS) Q5RFW0 (/ISS) Q6ZMJ2 (/ISS)
Protein homotrimerization GO:0070207
The formation of a protein homotrimer, a macromolecular structure consisting of three noncovalently associated identical subunits.
3 A5PJQ2 (/ISS) Q5RFW0 (/ISS) Q6ZMJ2 (/ISS)
Response to hypoxia GO:0001666
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.
2 P58022 (/IDA) P58022 (/IDA)
Positive regulation of protein phosphorylation GO:0001934
Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to amino acids within a protein.
2 G3V8U0 (/IDA) Q5FVU4 (/IDA)
Endothelial cell proliferation GO:0001935
The multiplication or reproduction of endothelial cells, resulting in the expansion of a cell population. Endothelial cells are thin flattened cells which line the inside surfaces of body cavities, blood vessels, and lymph vessels, making up the endothelium.
2 Q9Y4K0 (/IMP) Q9Y4K0 (/IMP)
Endothelial cell proliferation GO:0001935
The multiplication or reproduction of endothelial cells, resulting in the expansion of a cell population. Endothelial cells are thin flattened cells which line the inside surfaces of body cavities, blood vessels, and lymph vessels, making up the endothelium.
2 P58022 (/ISO) P58022 (/ISO)
Sprouting angiogenesis GO:0002040
The extension of new blood vessels from existing capillaries into avascular tissues resulting from the proliferation of blood vessel endothelial cells.
2 P58022 (/ISO) P58022 (/ISO)
Cellular protein modification process GO:0006464
The covalent alteration of one or more amino acids occurring in proteins, peptides and nascent polypeptides (co-translational, post-translational modifications) occurring at the level of an individual cell. Includes the modification of charged tRNAs that are destined to occur in a protein (pre-translation modification).
2 Q9Y4K0 (/IDA) Q9Y4K0 (/IDA)
Cellular protein modification process GO:0006464
The covalent alteration of one or more amino acids occurring in proteins, peptides and nascent polypeptides (co-translational, post-translational modifications) occurring at the level of an individual cell. Includes the modification of charged tRNAs that are destined to occur in a protein (pre-translation modification).
2 P58022 (/ISO) P58022 (/ISO)
Cellular protein modification process GO:0006464
The covalent alteration of one or more amino acids occurring in proteins, peptides and nascent polypeptides (co-translational, post-translational modifications) occurring at the level of an individual cell. Includes the modification of charged tRNAs that are destined to occur in a protein (pre-translation modification).
2 Q9Y4K0 (/TAS) Q9Y4K0 (/TAS)
Inflammatory response GO:0006954
The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages.
2 Q9Z175 (/IMP) Q9Z175 (/IMP)
Cell adhesion GO:0007155
The attachment of a cell, either to another cell or to an underlying substrate such as the extracellular matrix, via cell adhesion molecules.
2 Q9Y4K0 (/TAS) Q9Y4K0 (/TAS)
Aging GO:0007568
A developmental process that is a deterioration and loss of function over time. Aging includes loss of functions such as resistance to disease, homeostasis, and fertility, as well as wear and tear. Aging includes cellular senescence, but is more inclusive. May precede death and may succeed developmental maturation (GO:0021700).
2 Q9Y4K0 (/TAS) Q9Y4K0 (/TAS)
Histone modification GO:0016570
The covalent alteration of one or more amino acid residues within a histone protein.
2 Q9Y4K0 (/IDA) Q9Y4K0 (/IDA)
Histone modification GO:0016570
The covalent alteration of one or more amino acid residues within a histone protein.
2 P58022 (/ISO) P58022 (/ISO)
Peptidyl-lysine oxidation GO:0018057
The oxidation of the terminal amino-methylene groups of peptidyl-L-lysine or peptidyl-5-hydroxy-L-lysine to aldehyde groups to form allysine or hydroxyallysine residues, respectively; these are intermediates in the formation of covalent cross-links between adjacent polypeptide chains in proteins such as collagens.
2 Q9Z175 (/ISO) Q9Z175 (/ISO)
Protein deamination GO:0018277
The removal of an amino group from a protein amino acid.
2 Q9Y4K0 (/IDA) Q9Y4K0 (/IDA)
Protein deamination GO:0018277
The removal of an amino group from a protein amino acid.
2 P58022 (/ISO) P58022 (/ISO)
Spinal cord development GO:0021510
The process whose specific outcome is the progression of the spinal cord over time, from its formation to the mature structure. The spinal cord primarily conducts sensory and motor nerve impulses between the brain and the peripheral nervous tissues.
2 Q9Z175 (/IMP) Q9Z175 (/IMP)
Collagen fibril organization GO:0030199
Any process that determines the size and arrangement of collagen fibrils within an extracellular matrix.
2 Q9Y4K0 (/IMP) Q9Y4K0 (/IMP)
Collagen fibril organization GO:0030199
Any process that determines the size and arrangement of collagen fibrils within an extracellular matrix.
2 P58022 (/ISO) P58022 (/ISO)
Lung development GO:0030324
The process whose specific outcome is the progression of the lung over time, from its formation to the mature structure. In all air-breathing vertebrates the lungs are developed from the ventral wall of the oesophagus as a pouch which divides into two sacs. In amphibians and many reptiles the lungs retain very nearly this primitive sac-like character, but in the higher forms the connection with the esophagus becomes elongated into the windpipe and the inner walls of the sacs become more and more divided, until, in the mammals, the air spaces become minutely divided into tubes ending in small air cells, in the walls of which the blood circulates in a fine network of capillaries. In mammals the lungs are more or less divided into lobes, and each lung occupies a separate cavity in the thorax.
2 Q9Z175 (/IMP) Q9Z175 (/IMP)
Positive regulation of chondrocyte differentiation GO:0032332
Any process that activates or increases the frequency, rate or extent of chondrocyte differentiation.
2 P58022 (/IMP) P58022 (/IMP)
Endothelial cell migration GO:0043542
The orderly movement of an endothelial cell into the extracellular matrix to form an endothelium.
2 Q9Y4K0 (/IMP) Q9Y4K0 (/IMP)
Endothelial cell migration GO:0043542
The orderly movement of an endothelial cell into the extracellular matrix to form an endothelium.
2 P58022 (/ISO) P58022 (/ISO)
Response to copper ion GO:0046688
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a copper ion stimulus.
2 Q9Y4K0 (/IDA) Q9Y4K0 (/IDA)
Response to copper ion GO:0046688
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a copper ion stimulus.
2 P58022 (/ISO) P58022 (/ISO)
Embryonic viscerocranium morphogenesis GO:0048703
The process in which the anatomical structures of the viscerocranium are generated and organized during the embryonic phase. The viscerocranium is the part of the skull comprising the facial bones.
2 B8A4W9 (/IMP) B8A4W9 (/IMP)
Oxidation-reduction process GO:0055114
A metabolic process that results in the removal or addition of one or more electrons to or from a substance, with or without the concomitant removal or addition of a proton or protons.
2 Q9Y4K0 (/IDA) Q9Y4K0 (/IDA)
Oxidation-reduction process GO:0055114
A metabolic process that results in the removal or addition of one or more electrons to or from a substance, with or without the concomitant removal or addition of a proton or protons.
2 P58022 (/ISO) P58022 (/ISO)
Palate development GO:0060021
The biological process whose specific outcome is the progression of the palate from an initial condition to its mature state. This process begins with the formation of the structure and ends with the mature structure. The palate is the partition that separates the nasal and oral cavities.
2 Q9Z175 (/IMP) Q9Z175 (/IMP)
Somite development GO:0061053
The progression of a somite from its initial formation to the mature structure. Somites are mesodermal clusters that are arranged segmentally along the anterior posterior axis of an embryo.
2 Q9Z175 (/IMP) Q9Z175 (/IMP)
Fibronectin fibril organization GO:1905590
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a fibronectin fibril.
2 Q9Z175 (/IMP) Q9Z175 (/IMP)
Negative regulation of T-helper 17 cell lineage commitment GO:2000329
Any process that stops, prevents or reduces the frequency, rate or extent of T-helper 17 cell lineage commitment.
2 Q9Z175 (/IMP) Q9Z175 (/IMP)
Positive regulation of integrin-mediated signaling pathway GO:2001046
Any process that activates or increases the frequency, rate or extent of integrin-mediated signaling pathway.
2 Q9Z175 (/IMP) Q9Z175 (/IMP)
Immunological synapse formation GO:0001771
The formation of an area of close contact between a lymphocyte (T-, B-, or natural killer cell) and a target cell through the clustering of particular signaling and adhesion molecules and their associated membrane rafts on both the lymphocyte and target cell, which facilitates activation of the lymphocyte, transfer of membrane from the target cell to the lymphocyte, and in some situations killing of the target cell through release of secretory granules and/or death-pathway ligand-receptor interaction.
1 P30203 (/IMP)
Immunological synapse formation GO:0001771
The formation of an area of close contact between a lymphocyte (T-, B-, or natural killer cell) and a target cell through the clustering of particular signaling and adhesion molecules and their associated membrane rafts on both the lymphocyte and target cell, which facilitates activation of the lymphocyte, transfer of membrane from the target cell to the lymphocyte, and in some situations killing of the target cell through release of secretory granules and/or death-pathway ligand-receptor interaction.
1 Q61003 (/ISO)
Immunological synapse formation GO:0001771
The formation of an area of close contact between a lymphocyte (T-, B-, or natural killer cell) and a target cell through the clustering of particular signaling and adhesion molecules and their associated membrane rafts on both the lymphocyte and target cell, which facilitates activation of the lymphocyte, transfer of membrane from the target cell to the lymphocyte, and in some situations killing of the target cell through release of secretory granules and/or death-pathway ligand-receptor interaction.
1 Q61003 (/ISS)
Acute inflammatory response to antigenic stimulus GO:0002438
An acute inflammatory response to an antigenic stimulus. An acute inflammatory response occurs within a matter of minutes or hours, and either resolves within a few days or becomes a chronic inflammatory response.
1 P30203 (/IDA)
Acute inflammatory response to antigenic stimulus GO:0002438
An acute inflammatory response to an antigenic stimulus. An acute inflammatory response occurs within a matter of minutes or hours, and either resolves within a few days or becomes a chronic inflammatory response.
1 Q61003 (/ISO)
Acute inflammatory response to antigenic stimulus GO:0002438
An acute inflammatory response to an antigenic stimulus. An acute inflammatory response occurs within a matter of minutes or hours, and either resolves within a few days or becomes a chronic inflammatory response.
1 Q61003 (/ISS)
Platelet degranulation GO:0002576
The regulated exocytosis of secretory granules containing preformed mediators such as histamine and serotonin by a platelet.
1 Q08380 (/TAS)
Heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules GO:0007157
The attachment of an adhesion molecule in one cell to a nonidentical adhesion molecule in an adjacent cell.
1 P30203 (/IMP)
Heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules GO:0007157
The attachment of an adhesion molecule in one cell to a nonidentical adhesion molecule in an adjacent cell.
1 Q61003 (/ISO)
Heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules GO:0007157
The attachment of an adhesion molecule in one cell to a nonidentical adhesion molecule in an adjacent cell.
1 Q61003 (/ISS)
Signal transduction GO:0007165
The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.
1 Q08380 (/TAS)
Regulation of gene expression GO:0010468
Any process that modulates the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA (for protein-coding genes) and the translation of that mRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
1 Q6ZMJ2 (/IMP)
Regulation of blood coagulation GO:0030193
Any process that modulates the frequency, rate or extent of blood coagulation.
1 Q6ZMJ2 (/IMP)
Lipopolysaccharide-mediated signaling pathway GO:0031663
A series of molecular signals initiated by the binding of a lipopolysaccharide (LPS) to a receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription. Lipopolysaccharides are major components of the outer membrane of Gram-negative bacteria, making them prime targets for recognition by the immune system.
1 P30203 (/IDA)
Lipopolysaccharide-mediated signaling pathway GO:0031663
A series of molecular signals initiated by the binding of a lipopolysaccharide (LPS) to a receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription. Lipopolysaccharides are major components of the outer membrane of Gram-negative bacteria, making them prime targets for recognition by the immune system.
1 Q61003 (/ISO)
Lipopolysaccharide-mediated signaling pathway GO:0031663
A series of molecular signals initiated by the binding of a lipopolysaccharide (LPS) to a receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription. Lipopolysaccharides are major components of the outer membrane of Gram-negative bacteria, making them prime targets for recognition by the immune system.
1 Q61003 (/ISS)
Response to lipopolysaccharide GO:0032496
Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria.
1 P30203 (/IDA)
Response to lipopolysaccharide GO:0032496
Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria.
1 Q61003 (/ISO)
Response to lipopolysaccharide GO:0032496
Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria.
1 Q61003 (/ISS)
Positive regulation of T cell proliferation GO:0042102
Any process that activates or increases the rate or extent of T cell proliferation.
1 P30203 (/IMP)
Positive regulation of T cell proliferation GO:0042102
Any process that activates or increases the rate or extent of T cell proliferation.
1 Q61003 (/ISO)
Positive regulation of T cell proliferation GO:0042102
Any process that activates or increases the rate or extent of T cell proliferation.
1 Q61003 (/ISS)
Positive regulation of cytokine production involved in inflammatory response GO:1900017
Any process that activates or increases the frequency, rate or extent of cytokine production involved in inflammatory response.
1 P30203 (/IDA)
Positive regulation of cytokine production involved in inflammatory response GO:1900017
Any process that activates or increases the frequency, rate or extent of cytokine production involved in inflammatory response.
1 Q61003 (/ISO)
Positive regulation of cytokine production involved in inflammatory response GO:1900017
Any process that activates or increases the frequency, rate or extent of cytokine production involved in inflammatory response.
1 Q61003 (/ISS)

There are 51 GO terms relating to "cellular component"

The search results have been sorted with the annotations that are found most frequently at the top of the list. The results can be filtered by typing text into the search box at the top of the table.
GO Term Annotations Evidence
Extrinsic component of membrane GO:0019898
The component of a membrane consisting of gene products and protein complexes that are loosely bound to one of its surfaces, but not integrated into the hydrophobic region.
30 Q4A3R3 (/ISS) Q4A3R3 (/ISS) Q4A3R3 (/ISS) Q4A3R3 (/ISS) Q8CIZ5 (/ISS) Q8CIZ5 (/ISS) Q8CIZ5 (/ISS) Q8CIZ5 (/ISS) Q95218 (/ISS) Q95218 (/ISS)
(20 more)
Zymogen granule membrane GO:0042589
The lipid bilayer surrounding a zymogen granule.
30 Q4A3R3 (/ISS) Q4A3R3 (/ISS) Q4A3R3 (/ISS) Q4A3R3 (/ISS) Q8CIZ5 (/ISS) Q8CIZ5 (/ISS) Q8CIZ5 (/ISS) Q8CIZ5 (/ISS) Q95218 (/ISS) Q95218 (/ISS)
(20 more)
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
27 P58022 (/IDA) P58022 (/IDA) Q07797 (/IDA) Q08380 (/IDA) Q8BV57 (/IDA) Q8BV57 (/IDA) Q8BV57 (/IDA) Q8BV57 (/IDA) Q8BV57 (/IDA) Q9UGM3 (/IDA)
(17 more)
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
22 A1L4H1 (/ISS) A1L4H1 (/ISS) A1L4H1 (/ISS) A1L4H1 (/ISS) A6H737 (/ISS) A6H737 (/ISS) B4F6N6 (/ISS) B4F6N6 (/ISS) B5DF27 (/ISS) B5DF27 (/ISS)
(12 more)
Extracellular region GO:0005576
The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
20 Q08380 (/TAS) Q8BV57 (/TAS) Q8BV57 (/TAS) Q8BV57 (/TAS) Q8BV57 (/TAS) Q8BV57 (/TAS) Q9UGM3 (/TAS) Q9UGM3 (/TAS) Q9UGM3 (/TAS) Q9UGM3 (/TAS)
(10 more)
Extracellular exosome GO:0070062
A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
20 O43866 (/IDA) O43866 (/IDA) Q08380 (/IDA) Q8WTU2 (/IDA) Q8WTU2 (/IDA) Q8WTU2 (/IDA) Q9UGM3 (/IDA) Q9UGM3 (/IDA) Q9UGM3 (/IDA) Q9UGM3 (/IDA)
(10 more)
Basement membrane GO:0005604
A thin layer of dense material found in various animal tissues interposed between the cells and the adjacent connective tissue. It consists of the basal lamina plus an associated layer of reticulin fibers.
18 A1L1V4 (/ISS) A1L1V4 (/ISS) A6H737 (/ISS) A6H737 (/ISS) B4F6N6 (/ISS) B4F6N6 (/ISS) E1C3U7 (/ISS) E1C3U7 (/ISS) F1QQC3 (/ISS) F1QQC3 (/ISS)
(8 more)
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
17 F6PEI8 (/IDA) P58215 (/IDA) P58215 (/IDA) Q9UGM3 (/IDA) Q9UGM3 (/IDA) Q9UGM3 (/IDA) Q9UGM3 (/IDA) Q9UGM3 (/IDA) Q9UGM3 (/IDA) Q9UGM3 (/IDA)
(7 more)
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
17 A0A1B0GSB0 (/IDA) A0A1B0GSB0 (/IDA) A0A1B0GSB0 (/IDA) A0A1B0GSB0 (/IDA) A0A1B0GSB0 (/IDA) Q86VB7 (/IDA) Q86VB7 (/IDA) Q86VB7 (/IDA) Q86VB7 (/IDA) Q86VB7 (/IDA)
(7 more)
External side of plasma membrane GO:0009897
The leaflet of the plasma membrane that faces away from the cytoplasm and any proteins embedded or anchored in it or attached to its surface.
17 B3F5L4 (/IDA) B3F5L4 (/IDA) B3F5L4 (/IDA) B3F5L4 (/IDA) B3F5L5 (/IDA) B3F5L5 (/IDA) B3F5L5 (/IDA) B3F5L5 (/IDA) Q86VB7 (/IDA) Q86VB7 (/IDA)
(7 more)
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
14 A6H737 (/ISS) A6H737 (/ISS) B5DF27 (/ISS) B5DF27 (/ISS) B8A4W9 (/ISS) B8A4W9 (/ISS) F1RD85 (/ISS) F1RD85 (/ISS) P58022 (/ISS) P58022 (/ISS)
(4 more)
Phagocytic vesicle membrane GO:0030670
The lipid bilayer surrounding a phagocytic vesicle.
14 Q9UGM3 (/IDA) Q9UGM3 (/IDA) Q9UGM3 (/IDA) Q9UGM3 (/IDA) Q9UGM3 (/IDA) Q9UGM3 (/IDA) Q9UGM3 (/IDA) Q9UGM3 (/IDA) Q9UGM3 (/IDA) Q9UGM3 (/IDA)
(4 more)
Extracellular exosome GO:0070062
A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
14 A1L0T3 (/ISO) A1L0T3 (/ISO) A1L0T3 (/ISO) Q07797 (/ISO) Q60997 (/ISO) Q60997 (/ISO) Q60997 (/ISO) Q60997 (/ISO) Q60997 (/ISO) Q60997 (/ISO)
(4 more)
Intracellular GO:0005622
The living contents of a cell; the matter contained within (but not including) the plasma membrane, usually taken to exclude large vacuoles and masses of secretory or ingested material. In eukaryotes it includes the nucleus and cytoplasm.
13 Q60997 (/IDA) Q60997 (/IDA) Q60997 (/IDA) Q60997 (/IDA) Q60997 (/IDA) Q60997 (/IDA) Q60997 (/IDA) Q60997 (/IDA) Q8BV57 (/IDA) Q8BV57 (/IDA)
(3 more)
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
11 P58022 (/ISO) P58022 (/ISO) Q07797 (/ISO) Q60997 (/ISO) Q60997 (/ISO) Q60997 (/ISO) Q60997 (/ISO) Q60997 (/ISO) Q60997 (/ISO) Q60997 (/ISO)
(1 more)
Extracellular matrix GO:0031012
A structure lying external to one or more cells, which provides structural support for cells or tissues.
11 Q8BV57 (/IDA) Q8BV57 (/IDA) Q8BV57 (/IDA) Q8BV57 (/IDA) Q8BV57 (/IDA) Q8CIZ5 (/IDA) Q8CIZ5 (/IDA) Q8CIZ5 (/IDA) Q8CIZ5 (/IDA) Q9Y4K0 (/IDA)
(1 more)
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
10 Q60997 (/ISO) Q60997 (/ISO) Q60997 (/ISO) Q60997 (/ISO) Q60997 (/ISO) Q60997 (/ISO) Q60997 (/ISO) Q60997 (/ISO) Q9Z175 (/ISO) Q9Z175 (/ISO)
Proteinaceous extracellular matrix GO:0005578
A layer consisting mainly of proteins (especially collagen) and glycosaminoglycans (mostly as proteoglycans) that forms a sheet underlying or overlying cells such as endothelial and epithelial cells. The proteins are secreted by cells in the vicinity. An example of this component is found in Mus musculus.
8 Q60997 (/IDA) Q60997 (/IDA) Q60997 (/IDA) Q60997 (/IDA) Q60997 (/IDA) Q60997 (/IDA) Q60997 (/IDA) Q60997 (/IDA)
Integral component of plasma membrane GO:0005887
The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
8 P30203 (/TAS) Q86VB7 (/TAS) Q86VB7 (/TAS) Q86VB7 (/TAS) Q86VB7 (/TAS) Q86VB7 (/TAS) Q86VB7 (/TAS) Q86VB7 (/TAS)
Extrinsic component of membrane GO:0019898
The component of a membrane consisting of gene products and protein complexes that are loosely bound to one of its surfaces, but not integrated into the hydrophobic region.
8 Q60997 (/IDA) Q60997 (/IDA) Q60997 (/IDA) Q60997 (/IDA) Q60997 (/IDA) Q60997 (/IDA) Q60997 (/IDA) Q60997 (/IDA)
Phagocytic vesicle membrane GO:0030670
The lipid bilayer surrounding a phagocytic vesicle.
8 Q60997 (/ISO) Q60997 (/ISO) Q60997 (/ISO) Q60997 (/ISO) Q60997 (/ISO) Q60997 (/ISO) Q60997 (/ISO) Q60997 (/ISO)
Zymogen granule membrane GO:0042589
The lipid bilayer surrounding a zymogen granule.
8 Q60997 (/IDA) Q60997 (/IDA) Q60997 (/IDA) Q60997 (/IDA) Q60997 (/IDA) Q60997 (/IDA) Q60997 (/IDA) Q60997 (/IDA)
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
7 Q2VLH6 (/ISO) Q2VLH6 (/ISO) Q2VLH6 (/ISO) Q2VLH6 (/ISO) Q2VLH6 (/ISO) Q2VLH6 (/ISO) Q2VLH6 (/ISO)
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
7 Q86VB7 (/TAS) Q86VB7 (/TAS) Q86VB7 (/TAS) Q86VB7 (/TAS) Q86VB7 (/TAS) Q86VB7 (/TAS) Q86VB7 (/TAS)
External side of plasma membrane GO:0009897
The leaflet of the plasma membrane that faces away from the cytoplasm and any proteins embedded or anchored in it or attached to its surface.
7 Q2VLH6 (/ISO) Q2VLH6 (/ISO) Q2VLH6 (/ISO) Q2VLH6 (/ISO) Q2VLH6 (/ISO) Q2VLH6 (/ISO) Q2VLH6 (/ISO)
Endocytic vesicle membrane GO:0030666
The lipid bilayer surrounding an endocytic vesicle.
7 Q86VB7 (/TAS) Q86VB7 (/TAS) Q86VB7 (/TAS) Q86VB7 (/TAS) Q86VB7 (/TAS) Q86VB7 (/TAS) Q86VB7 (/TAS)
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
6 B8A4W9 (/ISS) B8A4W9 (/ISS) F1RD85 (/ISS) F1RD85 (/ISS) Q9Z175 (/ISS) Q9Z175 (/ISS)
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
5 O43866 (/TAS) O43866 (/TAS) Q08380 (/TAS) Q9Y4K0 (/TAS) Q9Y4K0 (/TAS)
Intracellular GO:0005622
The living contents of a cell; the matter contained within (but not including) the plasma membrane, usually taken to exclude large vacuoles and masses of secretory or ingested material. In eukaryotes it includes the nucleus and cytoplasm.
4 A1L4H1 (/ISS) A1L4H1 (/ISS) A1L4H1 (/ISS) A1L4H1 (/ISS)
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
4 P58215 (/IDA) P58215 (/IDA) Q9Y4K0 (/IDA) Q9Y4K0 (/IDA)
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
4 P58022 (/ISO) P58022 (/ISO) Q9Z175 (/ISO) Q9Z175 (/ISO)
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
4 P58215 (/TAS) P58215 (/TAS) Q9Y4K0 (/TAS) Q9Y4K0 (/TAS)
Extracellular matrix GO:0031012
A structure lying external to one or more cells, which provides structural support for cells or tissues.
4 A1L4H1 (/ISS) A1L4H1 (/ISS) A1L4H1 (/ISS) A1L4H1 (/ISS)
Integral component of plasma membrane GO:0005887
The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
3 A5PJQ2 (/ISS) Q5RFW0 (/ISS) Q6ZMJ2 (/ISS)
Blood microparticle GO:0072562
A phospholipid microvesicle that is derived from any of several cell types, such as platelets, blood cells, endothelial cells, or others, and contains membrane receptors as well as other proteins characteristic of the parental cell. Microparticles are heterogeneous in size, and are characterized as microvesicles free of nucleic acids.
3 O43866 (/IDA) O43866 (/IDA) Q08380 (/IDA)
Blood microparticle GO:0072562
A phospholipid microvesicle that is derived from any of several cell types, such as platelets, blood cells, endothelial cells, or others, and contains membrane receptors as well as other proteins characteristic of the parental cell. Microparticles are heterogeneous in size, and are characterized as microvesicles free of nucleic acids.
3 Q07797 (/ISO) Q9QWK4 (/ISO) Q9QWK4 (/ISO)
Extracellular region GO:0005576
The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
2 P58215 (/IDA) P58215 (/IDA)
Extracellular region GO:0005576
The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
2 Q9Z175 (/ISO) Q9Z175 (/ISO)
Extracellular region GO:0005576
The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
2 O43866 (/NAS) O43866 (/NAS)
Basement membrane GO:0005604
A thin layer of dense material found in various animal tissues interposed between the cells and the adjacent connective tissue. It consists of the basal lamina plus an associated layer of reticulin fibers.
2 B5DF27 (/IDA) B5DF27 (/IDA)
Nucleoplasm GO:0005654
That part of the nuclear content other than the chromosomes or the nucleolus.
2 Q9Y4K0 (/IDA) Q9Y4K0 (/IDA)
Nucleoplasm GO:0005654
That part of the nuclear content other than the chromosomes or the nucleolus.
2 P58022 (/ISO) P58022 (/ISO)
Extracellular matrix GO:0031012
A structure lying external to one or more cells, which provides structural support for cells or tissues.
2 P58022 (/ISO) P58022 (/ISO)
Spanning component of plasma membrane GO:0044214
The component of the plasma membrane consisting of gene products and protein complexes that have some part that spans both leaflets of the membrane.
2 G3V8U0 (/IDA) Q5FVU4 (/IDA)
Immunological synapse GO:0001772
An area of close contact between a lymphocyte (T-, B-, or natural killer cell) and a target cell formed through the clustering of particular signaling and adhesion molecules and their associated membrane rafts on both the lymphocyte and the target cell and facilitating activation of the lymphocyte, transfer of membrane from the target cell to the lymphocyte, and in some situations killing of the target cell through release of secretory granules and/or death-pathway ligand-receptor interaction.
1 P30203 (/IDA)
Immunological synapse GO:0001772
An area of close contact between a lymphocyte (T-, B-, or natural killer cell) and a target cell formed through the clustering of particular signaling and adhesion molecules and their associated membrane rafts on both the lymphocyte and the target cell and facilitating activation of the lymphocyte, transfer of membrane from the target cell to the lymphocyte, and in some situations killing of the target cell through release of secretory granules and/or death-pathway ligand-receptor interaction.
1 Q61003 (/ISO)
Immunological synapse GO:0001772
An area of close contact between a lymphocyte (T-, B-, or natural killer cell) and a target cell formed through the clustering of particular signaling and adhesion molecules and their associated membrane rafts on both the lymphocyte and the target cell and facilitating activation of the lymphocyte, transfer of membrane from the target cell to the lymphocyte, and in some situations killing of the target cell through release of secretory granules and/or death-pathway ligand-receptor interaction.
1 Q61003 (/ISS)
Platelet dense granule lumen GO:0031089
The volume enclosed by the membrane of the platelet dense granule.
1 Q08380 (/TAS)
Intrinsic component of plasma membrane GO:0031226
The component of the plasma membrane consisting of the gene products and protein complexes having either part of their peptide sequence embedded in the hydrophobic region of the membrane or some other covalently attached group such as a GPI anchor that is similarly embedded in the membrane.
1 P30203 (/IDA)
Intrinsic component of plasma membrane GO:0031226
The component of the plasma membrane consisting of the gene products and protein complexes having either part of their peptide sequence embedded in the hydrophobic region of the membrane or some other covalently attached group such as a GPI anchor that is similarly embedded in the membrane.
1 Q61003 (/ISO)
Intrinsic component of plasma membrane GO:0031226
The component of the plasma membrane consisting of the gene products and protein complexes having either part of their peptide sequence embedded in the hydrophobic region of the membrane or some other covalently attached group such as a GPI anchor that is similarly embedded in the membrane.
1 Q61003 (/ISS)